Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1707481000168110 | Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units injection, 1 x 0.5 mL syringe (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1707491000168113 | diphtheria toxoid 2 units + tetanus toxoid 20 units + Bordetella pertussis toxoid 8 microgram + Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + poliovirus type 1 inactivated antigen 40 D antigen units + poliovirus type 2 inactivated antigen 8 D antigen units + poliovirus type 3 inactivated antigen 32 D antigen units injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 1963401000168115 | diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2003001000168119 | dTpa-IPV (diphtheria + tetanus + pertussis 3 component + inactivated poliomyelitis vaccine) injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe | Is a | diphtheria + tetanus + pertussis 3 component adolescent/adult vaccine injection, 0.5 mL syringe | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe | Is a | polio trivalent inactivated vaccine injection, 0.5 mL syringe | true | Inferred relationship | Some | ||
| diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe | has MPUU | diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Boostrix-IPV (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL syringe (trade product pack) | Is a | True | diphtheria + tetanus + pertussis 3 component + polio trivalent adolescent/adult vaccine injection, 0.5 mL syringe | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set
FHIR